Market Research Logo

Vical Incorporated (VICL) - Financial and Strategic SWOT Analysis Review

Vical Incorporated (VICL) - Financial and Strategic SWOT Analysis Review

- provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and weaknesses and the potential opportunities and threats. The profile helps you formulate strategies that augment your business by enabling you to understand your partners, customers and competitors better.

The profile contains critical company information including:

  • Business description – A detailed description of the company’s operations and business divisions.
  • Corporate strategy – Analyst’s summarization of the company’s business strategy.
  • SWOT Analysis – A detailed analysis of the company’s strengths, weakness, opportunities and threats.
  • Company history – Progression of key events associated with the company.
  • Major products and services – A list of major products, services and brands of the company.
  • Key competitors – A list of key competitors to the company.
  • Key employees – A list of the key executives of the company.
  • Executive biographies – A brief summary of the executives’ employment history.
  • Key operational heads – A list of personnel heading key departments/functions.
  • Important locations and subsidiaries – A list and contact details of key locations and subsidiaries of the company.
  • Key manufacturing facilities – A list of key manufacturing facilities of the company.
  • Detailed financial ratios for the past five years – The latest financial ratios derived from the annual financial statements published by the company with 5 years history.
  • Interim ratios for the last five interim periods – The latest financial ratios derived from the quarterly/semi-annual financial statements published by the company for 5 interims history.
Highlights

Vical Incorporated (Vical) is a biopharmaceutical company, which focuses on research and development on DNA delivery technologies for the prevention and treatment of life-threatening diseases and vaccines for infectious diseases and cardiovascular therapies, in which the expressed protein is an angiogenic growth factor. Vaxfectin Adjuvant is a proprietary cationic lipid-based formulation it is a protein--based vaccines. The Company’s DNA delivery technology takes up polynucleotide genetic material, such as DNA or RNA.The company has collaborations with major pharmaceutical companies and biotechnology companies that give it access to complementary technologies or greater resources. Vical is headquartered in California, the US.

Vical Incorporated Key Recent Developments

May 09, 2016: Vical Reports First Quarter 2016 Financial Results
Mar 14, 2016: Vical Reports Fourth Quarter 2015 Financial Results
Dec 21, 2015: Vical Appoints Dr. Thomas Shenk to Board of Directors
Jul 30, 2015: Vical Reports Second Quarter 2015 Financial Results and Progress in Key Development Programs
May 08, 2015: Vical Reports First Quarter 2015 Financial Results and Progress in Key Development Programs

Key benefits of buying this profile include:

You get detailed information about the company and its operations to identify potential customers and suppliers.
The profile analyzes the company’s business structure, operations, major products and services, prospects, locations and subsidiaries, key executives and their biographies and key competitors.

Understand and respond to your competitors’ business structure and strategies, and capitalize on their weaknesses. Stay up to date on the major developments affecting the company.
The company’s core strengths and weaknesses and areas of development or decline are analyzed and presented in the profile objectively. Recent developments in the company covered in the profile help you track important events.

Equip yourself with information that enables you to sharpen your strategies and transform your operations profitably.
Opportunities that the company can explore and exploit are sized up and its growth potential assessed in the profile. Competitive and/or technological threats are highlighted.

Scout for potential investments and acquisition targets, with detailed insight into the companies’ strategic, financial and operational performance.
Financial ratio presented for major public companies in the profile include the revenue trends, profitability, growth, margins and returns, liquidity and leverage, financial position and efficiency ratios.

Gain key insights into the company for academic or business research.
Key elements such as SWOT analysis, corporate strategy and financial ratios and charts are incorporated in the profile to assist your academic or business research needs.

Note: Some sections may be missing if data is unavailable for the company


Section 1 - About the Company
Vical Incorporated - Key Facts
Vical Incorporated - Key Employees
Vical Incorporated - Key Employee Biographies
Vical Incorporated - Major Products and Services
Vical Incorporated - Pharmaceutical Pipeline Products Data
Vical Incorporated, Pipeline Products by Therapy Area
Vical Incorporated, Pipeline Products by Development Phase
Vical Incorporated - History
Vical Incorporated - Company Statement
Vical Incorporated - Locations And Subsidiaries
Head Office
Section 2 – Company Analysis
Vical Incorporated - Business Description
Vical Incorporated - Corporate Strategy
Vical Incorporated - SWOT Analysis
SWOT Analysis - Overview
Vical Incorporated - Strengths
Strength - Focused Research and Development Activities
Strength - Proprietary DNA Delivery Technology
Vical Incorporated - Weaknesses
Weakness - History of Operating Losses
Weakness - Working Capital Concerns
Vical Incorporated - Opportunities
Opportunity - Focus on Cancer Vaccines
Opportunity - Product Pipeline
Opportunity - Strategic Partnerships
Vical Incorporated - Threats
Threat - Product Liability Claims
Threat - Increasing Competitive Pressures
Threat - Stringent Government Regulations
Threat - Reliance on Third Parties for Clinical Trials
Vical Incorporated - Key Competitors
Section 3 – Company Financial Ratios
Financial Ratios - Capital Market Ratios
Financial Ratios - Annual Ratios
Performance Chart
Financial Performance
Financial Ratios - Interim Ratios
Financial Ratios - Ratio Charts
Section 4 – Company’s Lifesciences Financial Deals and Alliances
Vical Incorporated, Pharmaceuticals & Healthcare, Deals By Year, 2010 to YTD 2016
Vical Incorporated, Pharmaceuticals & Healthcare, Deals By Type, 2010 to YTD 2016
Vical Incorporated, Recent Deals Summary
Section 5 – Company’s Recent Developments
May 09, 2016: Vical Reports First Quarter 2016 Financial Results
Mar 14, 2016: Vical Reports Fourth Quarter 2015 Financial Results
Dec 21, 2015: Vical Appoints Dr. Thomas Shenk to Board of Directors
Jul 30, 2015: Vical Reports Second Quarter 2015 Financial Results and Progress in Key Development Programs
May 08, 2015: Vical Reports First Quarter 2015 Financial Results and Progress in Key Development Programs
Feb 26, 2015: Vical Reports Fourth Quarter 2014 Financial Results and Progress in Key Development Programs
Section 6 – Appendix
Methodology
Ratio Definitions
About GlobalData
Contact Us
Disclaimer
List of Tables
Vical Incorporated, Key Facts
Vical Incorporated, Key Employees
Vical Incorporated, Key Employee Biographies
Vical Incorporated, Major Products and Services
Vical Incorporated, Number of Pipeline Products by Therapy Area
Vical Incorporated, Number of Pipeline Products by Development Stage
Vical Incorporated, Pipeline Products By Therapy Area and Development Phase
Vical Incorporated, History
Vical Incorporated, Key Competitors
Vical Incorporated, Ratios based on current share price
Vical Incorporated, Annual Ratios
Vical Incorporated, Interim Ratios
Vical Incorporated, Pharmaceuticals & Healthcare, Deals By Year, 2010 to YTD 2016
Vical Incorporated, Pharmaceuticals & Healthcare, Deals By Type, 2010 to YTD 2016
Vical Incorporated, Recent Deals Summary
Currency Codes
Capital Market Ratios
Equity Ratios
Profitability Ratios
Cost Ratios
Liquidity Ratios
Leverage Ratios
Efficiency Ratios
List of Figures
Vical Incorporated, Pipeline Products by Therapy Area
Vical Incorporated, Pipeline Products by Development Phase
Vical Incorporated, Performance Chart (2011 - 2015)
Vical Incorporated, Ratio Charts
Vical Incorporated, Pharmaceuticals & Healthcare, Deals By Year, 2010 to YTD 2016
Vical Incorporated, Pharmaceuticals & Healthcare, Deals by Type, 2010 to YTD 2016

Download our eBook: How to Succeed Using Market Research

Learn how to effectively navigate the market research process to help guide your organization on the journey to success.

Download eBook

Share this report